PF-Atlas › Исследования › CrossRef Reversal
Исследования: CrossRef Reversal (14)
14 публикаций в теме «CrossRef Reversal», проиндексированных PF-Atlas из PubMed и мировых журналов.
- Regressor Aggregation with Random Positive Weights: Sign Reversal in Linear Regression · CrossRef · 2026
- Letter on ‘Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated <scp>MASH</scp> Cirrhosis for Fibrosis Regression and <scp>MASH</scp> Resolution’ · Alimentary Pharmacology & Therapeutics · 2026
- One to None: Fractal Regression, Parasitic Collapse, and the Reversal of Life's Scaffold · CrossRef · 2025
- Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis · Hepatology · 2025
- Grassroots Mediation and Dispute Resolution Mechanism Integrating Law and Ritual · Dispute and Resolution Mechanism in Modern China · 2025
- EPS3.04 Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases · Journal of Cystic Fibrosis · 2024
- Reversal of Liver Fibrosis: Is It a Reality · Bangladesh Journal of Medicine · 2024
- THU-523 Single cell resolution of hepatic heterogeneity in liver fibrosis progression and regression · Journal of Hepatology · 2024
- Retracted: Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology · Applied Bionics and Biomechanics · 2023
- Regulatory mechanism of CaMKII δ mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872 · Biomedicine & Pharmacotherapy · 2023
- Regression of Fibrosis and Reversal of Diastolic Dysfunction in HFPEF Patients Treated with Allogeneic CDCs · Stem Cell Surgery Trials in Heart Failure and Diabetes · 2022
- Revealing the DNA Unwinding Activity and Mechanism of Fork Reversal by Recg While Exposed to Variants of Stalled Replication-Fork at Single-Molecular Resolution · SSRN Electronic Journal · 2022
- Ruxolitinib Suppresses Liver Fibrosis Progression and Accelerates Fibrosis Reversal via Selectively Targeting Janus Kinase 1/2 · CrossRef · 2021
- Understanding the molecular mechanism associated with reversal of oral submucous fibrosis targeting hydroxylysine aldehyde-derived collagen cross-links · Journal of Carcinogenesis · 2021
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.